LLY Stock: Will Eli Lilly Still Win Big in 2026–2027? Insider Screener + Fundamentals and technicals
Eli Lilly (LLY) has been one of the best-performing pharmaceutical stocks in recent years, driven by explosive demand for its obesity and diabetes drugs like Mounjaro and Zepbound. But after the massive rally, the big question investors are asking is: what happens next in 2026–2027?
In this video, we break down Eli Lilly’s long-term growth outlook, focusing on its GLP-1 leadership, next-generation drugs such as retatrutide, and the company’s aggressive manufacturing expansion to meet global demand. We also analyze the key risks, including high valuation, competition from Novo Nordisk, and potential pricing pressure.
Whether you’re already holding LLY stock or considering a new position, this video will help you understand where Eli Lilly could be heading over the next two years and whether expectations are still realistic at current prices.
Topics covered:
Eli Lilly stock outlook for 2026–2027
Obesity & diabetes drug growth (Mounjaro, Zepbound, retatrutide)
Revenue and earnings drivers
Valuation risks and competition
Is LLY stock still a buy for long-term investors?
🔴 DISCLAIMER: All the information expressed by Trading HT is not financial advice in any way and therefore should not be considered as such under any circumstances. Everything expressed by Trading HT is for entertainment purposes and not specific for you. You should not treat any opinion or information expressed by Trading HT as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of their personal opinion and for entertainment purposes only. The information expressed by Trading HT does not take into account your particular investment objectives, financial situation or needs and is not intended as recommendations appropriate for you. Trading HT’s lessons are based upon information they consider reliable and you should not treat anything expressed by Trading HT as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of their personal opinion and for entertainment purposes only. Past performance is not indicative of future results and Trading HT does not guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed by Trading HT. Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned by Trading HT may not be suitable for you. This material does not take into account your particular investment objectives, financial situation or needs and it is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned by Trading HT. Before acting on information on these lessons, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice. We are not offering professional advice in any way. NOT FINANCIAL ADVICE.
📈 Sign up on TradingView with our affiliate link and get $15 + 2 months free in all annual plans. Only for new users: https://www.tradingview.com/?aff_id=134739
💚 Follow us on X: https://twitter.com/Trading_HT
🧡 HT on Instagram: https://www.instagram.com/trading_ht/
💙 HT on Telegram: https://t.me/trading_ht
👔 Sign up on Trading 212 Invest with our affiliate link and deposit at least $10 and get up to $100 in free shares. Only for new users: https://www.trading212.com/invite/FMA3U8Ck